Advertisement

Rheumatology International

, Volume 7, Issue 2, pp 77–82 | Cite as

Antinuclear antibodies in patients with systemic lupus erythematosus: a comparison of counterimmunoelectrophoresis and immunoblotting

  • A. A. A. Westgeest
  • H. G. van den Brink
  • J. de Jong
  • A. J. G. Swaak
  • R. J. T. Smeenk
Originals

Summary

Traditionally, the method used mostly to identify antinuclear antibody (ANA) specificities is the counterimmunoelectrophoresis technique (CIE), in which a salt extract of rabbit thymus powder (so-called extractable nuclear antigen or ENA) serves as the source of antigen. Recently, the immunoblotting technique (IBT) has been introduced in the serology of antinuclear antibodies. A nuclear extract of HeLa cells is generally used as antigen in this method. In this paper, we compared both methods using sera of patients with active systemic lupus erythematosus (SLE). Only anti-Sm, anti-RNP, and Anti-SSB were taken into consideration, as the former technique only allowed the identification of these specificities. Within these restrictions, we found that, of 77 patients with SLE, 21 had CIE-detectable antibodies in their circulation and 29 IBT-detectable antibodies. Anti-RNP and anti-SSB were detected more frequently with the CIE than with the IBT; anti-Sm, on the other hand, was detected more frequently with the IBT than with the CIE. Several significant correlations were found between incidences of measured antibody specificities and disease features. The presence of anti-RNP (both if measured with the IBT or with the CIE) was found to be negatively correlated with nephritis. If measured with the IBT, the presence of anti-Sm correlated negatively with hematological disorders, and the presence of anti-SSB correlated positively with renal involvement. Only if measured with the CIE did the presence of anti-SSB correlate negatively with central nervous system disorders.

Key words

Antinuclear antibodies Systemic lupus erythematosus Immunoblotting Sm, RNP, SSB 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bech JS (1961) Variations in the morphological patterns of “autoimmune” nuclear fluorescence. Lancet I:1203–1206Google Scholar
  2. 2.
    Moroy Y, Peebles C, Fritzler MJ, Steigerwald J, Tan EM (1980) Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 77:1627–1631Google Scholar
  3. 3.
    Tan EM (1982) Antibodies to nuclear antigens (ANA): their immunobiology and medicine. In: Kunkel HG, Dixon FJ (eds) Advances in immunology, vol 33. Academic Press, New York, pp 167–233Google Scholar
  4. 4.
    Smeenk RJT, Westgeest AAA, Swaak AJG (1985) Antinuclear antibody determination: the present state of diagnostic and clinical relevance. Scand J Rheumatol [Suppl] 56:78–92Google Scholar
  5. 5.
    Swaak AJG, Aarden LA, Statius van Eps LW, Feltkamp TEW (1979) Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum 22:226–235Google Scholar
  6. 6.
    Lerner MR, Steitz JA (1979) Antibodies to small nuclear RNA's complexed with proteins are produced by patients with SLE. Proc Natl Acad Sci USA 76:5495–5499Google Scholar
  7. 7.
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Green Schaller J, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of SLE. Arthritis Rheum 25:1271–1275Google Scholar
  8. 8.
    Swaak AJG, Groenwold J, Aarden LA, Statius van Eps LW, Feltkamp TEW (1982) Prognostic value of anti-dsDNA in SLE. Ann Rheum Dis 41 C:388–402Google Scholar
  9. 9.
    Aarden LA, De Groot ER, Feltkamp TEW (1975) Immunology of DNA. III. Crithidia luciliae a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann NY Acad Sci 254:505–515Google Scholar
  10. 10.
    Kurata N, Tan EM (1976) Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis Rheum 19:574–580Google Scholar
  11. 11.
    Tan EM, Fritzler MJ, McDougal JS, McDuffie FC, Nakamura RM, Reichlin M, Reimer ChB, Sharp GC, Schur PH, Wilson MR, Winchester RJ (1982) Reference sera for ANA. I. Antibodies to native DNA, Sm, nuclear RNP and SSB. Arthritis Rheum 25:1003–1005Google Scholar
  12. 12.
    Westgeest AAA, Brink HG Van den, Swaak AJG, Smeenk RJT (1985) Immunoblotting with nuclear antigens: a study of the diagnostic value. In: Peeters H (ed) Protides of the biological fluids, vol 33. Pergamon Press, London, 405–408Google Scholar
  13. 13.
    Laemmli U (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685Google Scholar
  14. 14.
    Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354Google Scholar
  15. 15.
    Westgeest AAA, Bons JC, Brink HG van den, Aarden LA, Smeenk RJT (1986) An improved incubation apparatus for western blots used for the detection of antinuclear antibodies. J Immunol Methods 95:283–288Google Scholar
  16. 16.
    Hawkes R, Miday E, Gordon J (1982) A dot-immunobinding assay for monoclonal and other antibodies. Anal Biochem 119:142–147Google Scholar
  17. 17.
    Swaak AJG, Van Rooyen A, Out TA, Smeenk RJT (1985) The qualitative and quantitative aspects of anti-dsDNA antibodies in systemic lupus erythematosus. In: Peeters H (ed) Protides of the biological fluids, vol 33. Pergamon Press, Oxford, pp 297–300Google Scholar
  18. 18.
    Habets WJ, De Rooy DJ, Salden MH, Verhagen AP, Van Eekelen CA, Van de Putte LBA, Van Venrooij WJ (1983) Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease. Clin Exp Immunol 54:265–276Google Scholar
  19. 19.
    Williams DG, Stocks MR, Charles PJ, Maini RN (1986) Antibodies to La, Jo-1, nRNP and Sm detected by multi-trade immunoblotting using a novel filter holder: a comparative study with counterimmunoelectrophoresis and immunodiffusion using sera from patients with systemic lupus erythematosus and Sjøgren's syndrome. J Immunol Methods 91:65–73Google Scholar
  20. 20.
    Reichlin M, Mattioli M (1972) Correlation of a precipitin reaction to an RNA-protein antigen and a low prevalence of nephritis in patients with SLE. N Engl J Med 286:908–911Google Scholar
  21. 21.
    Barada FA, Andrew BS, Davis IV JS, Taylor RP (1981) Antibodies to Sm in patients with SLE. Arthritis Rheum 24:1236–1244Google Scholar
  22. 22.
    Wasicek CA, Reichlin M (1982) Clinical and serological differences between SLE patients with antibodies to Ro versus patients with antibodies to Ro and La. J Clin Invest 69:835–843Google Scholar
  23. 23.
    Venables PJW, Charles PJ, Buchanan RRC, Yung T, Mumford PA, Schrieber L, Room GRW, Maini RN (1983) Quantitation and detection of isotypes of anti-SSB antibodies by Elisa and Farr assays using affinity-purified antigens. Arthritis Rheum 26:146–155Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • A. A. A. Westgeest
    • 1
  • H. G. van den Brink
    • 1
  • J. de Jong
    • 1
  • A. J. G. Swaak
    • 1
  • R. J. T. Smeenk
    • 1
  1. 1.Central Laboratory of the Netherlands Red Cross Blood Transfusion Service and Laboratory for Experimental and Clinical ImmunologyUniversity of AmsterdamAmsterdamThe Netherlands

Personalised recommendations